Posted in | News

Dow Coatings EVOQUE Receives R&D 100 Award

Dow Coating Materials announced that R&D Magazine recognized its EVOQUETM Technology as a R&D 100 Award Winner for 2013.

A panel of independent judges and the editors of R&D Magazine annually award excellence in innovation by selecting the top 100 products that represent leading technologies introduced in the previous year.

“This award is the culmination of many years of hard work for the Dow Coating Materials team and we’re thrilled to receive this honor from R&D Magazine,” said Ashok Kalyana, Architectural & Industrial Marketing Director for Dow Coating Materials.  “Customers worldwide have proven the value that EVOQUE Technology brings to the market and gaining this type of recognition from the industry serves to further validate the tremendous success we’ve had with this innovation.”

With EVOQUE Pre-Composite Polymer Technology, paint formulators have the opportunity to raise paint film performance, improve titanium dioxide (TiO2) efficiency and enhance the eco-profile of their paints.  In a recent Life Cycle Assessment, paints made with EVOQUE Technology were found to reduce the potential environmental impact of waterborne white and pastel architectural paints in ten out of ten key indicators.

“EVOQUE Pre-Composite Polymer offers performance properties that can help formulators create product lines that require fewer coats, are more resistant to stains and dirt, are easier to clean, and resist rusting, corrosion and other weather effects,” said Keith Watson, Global R&D Director for Dow Coating Materials.

Added Kalyana, “EVOQUETM Pre-Composite Polymer truly is a revolutionary technology that will change the way the industry makes paint, much like acrylic emulsions did some 50 years ago.”

The R&D Awards have identified revolutionary technologies since 1963.  Past winners of the R&D Awards span industry, academia and government-sponsored research and include iconic innovations such as the automated teller machine, the fax machine, the Nicoderm anti-smoking patch and HDTV.  Winners of the 2013 awards will be honored at a banquet on November 7 at the Renaissance Orlando Hotel at SeaWorld, Orlando, FL.  To learn more about EVOQUE Technology, go to www.dow.com/coating/hiding/.

About Dow Coating Materials

Dow Coating Materials is the most innovative coatings raw material supplier in the world; driving fundamental shifts in the coatings industry and moving the market as the expert’s expert in coatings solutions. Through its mission of collaboration, inspiration, innovation and growth, the business provides material products, science, technology, and manufacturing solutions to the architectural and industrial coatings industry worldwide.  Dow Coating Materials operates 43 manufacturing plants worldwide and 13 dedicated R&D facilities across all major geographic markets where Dow does business. For more information please visit http://www.dow.com/coating.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dow. (2019, February 09). Dow Coatings EVOQUE Receives R&D 100 Award. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=37805.

  • MLA

    Dow. "Dow Coatings EVOQUE Receives R&D 100 Award". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=37805>.

  • Chicago

    Dow. "Dow Coatings EVOQUE Receives R&D 100 Award". AZoM. https://www.azom.com/news.aspx?newsID=37805. (accessed November 23, 2024).

  • Harvard

    Dow. 2019. Dow Coatings EVOQUE Receives R&D 100 Award. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=37805.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.